Deletion of the distal short arm of chromosome 9 (9p) has been reported in a number of cases to be associated with gonadal dysgenesis and XY sex reversal, suggesting that this region contains one or more genes required in two copies for normal testis development. Recent studies have greatly narrowed the interval containing this putative autosomal testis-determining gene(s) to the distal portion of 9p24.3. We previously identified DMRT1, a human gene with sequence similarity to genes that regulate the sexual development of nematodes and insects. These genes contain a novel DNA-binding domain, which we named the DM domain. DMRT1 maps to 9p24.3 and in adults is expressed specifically in the testis. We have investigated the possible role of DM domain genes in 9p sex reversal. We identified a second DM domain gene, DMRT2, which also maps to 9p24.3. We found that point mutations in the coding region of DMRT1 and the DM domain of DMRT2 are not frequent in XY females. We showed by fluorescence in situ hybridization analysis that both genes are deleted in the smallest reported sex-reversing 9p deletion, suggesting that gonadal dysgenesis in 9p-deleted individuals might be due to combined hemizygosity of DMRT1 and DMRT2.
INTRODUCTION
Sexual development in mammals requires formation and differentiation of the gonads. In males, the gonad produces the hormones Müllerian inhibiting substance (also called antiMüllerian hormone) and testosterone, which together cause degeneration of the female Müllerian ducts and support the development of male sexual characteristics (1, 2) . Surgical removal of the gonads in early embryogenesis causes both XX and XY animals to undergo female somatic development, demonstrating that the only essential role for the gonads in sex determination is to promote male development (3) . This result also demonstrates that XY sex reversal would result either from failure to form the bipotential gonad or failure of sexual differentiation of the bipotential gonad once it has formed. Molecular analysis of sex reversal syndromes has led to the identification of a number of genes involved in the formation of the bipotential gonad or its subsequent sexual development. At least two of these genes are on the sex chromosomes, SRY (4-7), the testis-determining factor on the Y chromosome, and the Xlinked dosage sensitive sex reversal locus DSS, which contains the DAX1 gene (8) (9) (10) . Other genes are located on autosomes, including the steroidogenic factor 1 (SF1) gene on chromosome 9q (11, 12) , the Wilms tumor gene (WT1) on chromosome 11p (13) and the SOX9 gene on chromosome 17q (14) (15) (16) . Mutations in SRY affect only gonadal differentiation, while mutations in the other genes are associated with additional phenotypes in other organs. Mutations in known genes required for gonadal development account for a minority of cases of XY sex reversal (1, 2) . This clearly indicates that the majority of XY sex reversals must result from mutations at other chromosomal loci.
Deletions of chromosomes 9p and 10q have been associated with primary sex reversal of 46,XY individuals, indicating that these regions harbor genes essential for testicular development (17, 18) . In the case of 9p, relatively large deletions have been associated with a syndrome called 9p deletion syndrome, in which patients have phenotypes including mental retardation and craniofacial abnormalities (19) . XY individuals with 9p deletion syndrome have a high frequency of partial or complete sex reversal, with female or ambiguous external and internal genitalia and partial or complete gonadal dysgenesis (17, (20) (21) (22) (23) .
Smaller 9p deletions can cause the same extent of sex reversal and gonadal dysgenesis without the other symptoms of 9p deletion syndrome (24) (25) (26) (27) . This suggests that gonadal dysgenesis and the other symptoms of 9p deletion syndrome are caused by the loss of different genes. Molecular and cytogenetic analysis of 9p deletions in sex-reversed patients has identified a range of deletion breakpoints from 9p21 to 9p24, with no clear correlation between the extent of the deletion and the severity of sex reversal. The wide range of deletion breakpoints suggests that the deletions are removing, rather than interrupting, a critical gene. The smallest sex-reversing 9p deletions described delete only a portion of the most distal region, 9p24.3 (25, 27) . This suggests that one or more genes within the 9p24.3-9pter interval is required for testis development. The size of the minimal critical region in 9p24.3 is estimated at~250 kb based on the distance between D9S1779 (cosmid 67H3) and a subtelomeric cosmid clone (22E9) (28).
In many cases it has been possible to identify candidate genes involved in vertebrate development by studying invertebrate model organisms such as the nematode Caenorhabditis elegans and the fruitfly Drosophila. In the case of sex determination this approach has been less successful, as most sex-determining genes in these two organisms are molecularly unrelated and appear not to have homologs involved in mammalian sex determination (29) . Recently, however, we discovered an example of apparent evolutionary conservation in sex determination between nematodes and insects (30) . We found that the mab-3 gene of C.elegans, which is required for male sexual differentiation (31) , encodes a protein with a novel DNA-binding motif that also is found in the Drosophila sexual regulator doublesex (dsx) (32) (33) (34) (35) . We named this motif the DM domain after dsx and mab-3. These two genes appear to be evolutionarily conserved based on four criteria. First, both genes encode proteins with DM domains. Second, both genes control analogous aspects of sexual development. Third, both genes act downstream in their respective sex determination pathways. Fourth, the male splice form of DSX can functionally substitute for the mab-3 gene by restoring male-specific sense organ formation to a mab-3 mutant C.elegans male (30) . Thus, it is clear that DM domain proteins are essential for sexual development in the phyla Nematoda and Arthropoda. Based on the sex-determining roles of DM proteins in two species that diverged up to 500 million years ago, DM domain proteins are candidates to be involved in sex determination in other species as well.
We previously identified a human cDNA clone encoding a DM domain-containing protein, which we named DMRT1 (Doublesex and MAB-3 related transcription factor 1; formerly called DMT1) (30) . In adults, DMRT1 mRNA is expressed only in the testis (30) . Several recent studies have narrowed the smallest common region of overlap of 9p deletions associated with XY sex reversal to distal 9p24, suggesting that a gene or genes within this region is essential in two copies for testis development (24) (25) (26) (27) . Because DMRT1 maps to distal 9p24, has sequence similarity to known sex-determining genes of two other phyla and is expressed specifically in the testis, it is an excellent candidate to be involved in sex determination.
In this study we investigate whether DMRT1 or other DM domain-containing genes might play a role in human XY sex reversal. We show that the critical region of 9p24.3 contains not only DMRT1, but also a second DM domain-containing gene that we have named DMRT2. This suggests that sex reversal due to 9p deletion might result from loss of both genes. Consistent with this possibility, sequencing of the entire coding region of DMRT1 and the DNA-binding domain of DMRT2 from a large number of XY females revealed only a single possible point mutation in DMRT1. By fluorescence in situ hybridization (FISH) analysis we show that the smallest sex-reversing 9p deletion reported thus far removes both DMRT1 and DMRT2. Therefore, we suggest that XY sex reversal in 9p-deleted individuals may be due to hemizygosity of DMRT1 and DMRT2.
RESULTS

Organization of the DMRT1 gene
To determine the intron/exon organization and coding sequence of DMRT1 (Fig. 1A) , we determined the nucleotide sequence of a previously described DMRT1 cDNA clone (30) , used this cDNA as a probe to isolate clones from a human genomic DNA library and compared the cDNA and genomic sequences. To identify the 5'-end of the DMRT1 mRNA, which is at least 140 nt upstream of the first in-frame methionine codon and missing from the cDNA clone, we used 5'-RACE. The 3'-UTR and poly(A) addition site are present in the cDNA clone. DMRT1 is predicted to encode a 373 amino acid protein with a single DM DNA-binding domain near the N-terminus (Fig. 1A) .
Comparison of DMRT1 with two other DM domain-containing proteins, Doublesex (DSX) of Drosophila and MAB-3 of C.elegans, shows 67% identity to DSX and 50% identity to MAB-3 across the core C 2 H 2 C 4 region of the DM domain (30) . The only similarity between these proteins outside the DM domain is a region rich in prolines and serines (Fig. 1A) . The function of this region remains to be determined.
Identification of a second DM domain gene in 9p24.3
We also sought other DM domain genes that might lie within the minimal sex reversal region of 9p. We used a degenerate PCR strategy (C.S. Raymond, J.R. Kettlewell, E.D. Parker, K.J. Seifert, B. Hirsch, V.J. Bardwell and D. Zarkower, manuscript submitted for publication) to isolate a DNA clone encoding a DM domain highly similar to that of DMRT1. We have named this new gene DMRT2. To determine the DMRT2 coding sequence (Fig. 1B) we isolated a cDNA clone from a human adult testis library. Database searches also identified a partial DMRT2 cDNA sequence from an adult female muscle library, suggesting that DMRT2 expression is less spatially and sexually restricted than DMRT1 expression, at least in adults. Comparison of the DMRT1 and DMRT2 protein sequences revealed that the two proteins are 80% identical in the core region of the DM domain. Both proteins also contain an additional 29 amino acid conserved DM domain region found in a subset of DM domain proteins, including DSX and MAB-3 ( Fig. 1) . The N-terminal portion of DMRT2 is longer and more acidic than that of DMRT1, but both proteins have a number of conserved proline and glycine residues in the N-terminal portion. The C-terminal portion of DMRT2 is shorter than that of DMRT1 and is only~20% identical to the corresponding portion of DMRT1. We used FISH to show that DMRT2, like DMRT1, maps within 9p24.3 ( Fig. 2) . Thus, the sex reversal region of 9p contains two genes that are expressed in testis and have sequence similarity to known invertebrate sex-determining genes, either of which might potentially be involved in 9p sex reversal.
Sequencing of DMRT1 and DMRT2 from XY females and XX males
If DMRT1 or DMRT2 mutations are a frequent cause of human XY sex reversal, one might expect to find point mutations in the coding region among a large population of XY females. To test this possibility, we sequenced the entire coding region of DMRT1 and the DM domain of DMRT2 from a large number of sex-reversed individuals.
For DMRT1, we analyzed DNA from lymphoblastoid cell lines derived from 87 individuals with unexplained XY sex reversal (XY The 5'-end of the mRNA has not been precisely determined, but is at least 140 nt 5' of the first in-frame AUG. The DM domain and proline/serine-rich region are indicated by overlining; the C 2 H 2 C 4 core region of the DM domain is overlined with double dashes. Exon-exon boundaries are indicated by ∆. Codons affected by nucleotide changes in XY females, XX males or controls are indicated by underlining and numbering. Numbers of sequence changes correspond to those in Figure  2A. (B) Comparison of DMRT1 and DMRT2 protein sequences. Amino acid identities are boxed in black and similarities are shaded gray. Amino acids are numbered relative to the first in-frame methionine codon. Alignments were performed using the ClustalW program. GenBank accession nos of cDNA sequences are AF130728 (DMRT1) and AF130729 (DMRT2). females). We also analyzed DNA from 17 individuals with XX sex reversal (XX males) to test the possibility that dominant gain-offunction mutations in DMRT1 can cause female-to-male sex reversal. While 80-90% of human XX males carry the SRY gene, those studied here had all been found to lack SRY (L.G. Brown and D.C. Page, unpublished data). The XY females all have an SRY gene based on PCR amplification; in most cases the HMG domain of SRY was sequenced and found to be normal (P. Beer-Romero and D.C. Page, unpublished data). All of the patients have normal karyotypes. We used PCR to amplify, from genomic DNA, each exon and ∼100 bp of the adjacent intron or UTR sequence and directly sequenced the resulting DNA fragments using radiolabeled dideoxynucleotide terminator cycle sequencing. To differentiate between potential mutations and polymorphisms, DNA from a control population consisting of grandparents from the panel of Centre d'Etude du Polymorphisme Humain (CEPH) reference families was also sequenced.
We found nucleotide differences in DMRT1 at five positions among the sex-reversed patients (Figs 1 and 3A) . We also found a single silent mutation in a control individual (nucleotide change number 4; Figs 1 and 3A) . All sequence differences were heterozygous. Four changes are clearly polymorphisms, as they occur at similar frequency among the control group. A fifth, which causes a Pro→Leu coding change in exon 4 (nucleotide change number 6; Figs 1 and 3) , may be a loss-of-function mutation, as it was not found in 162 control chromosomes (81 individuals) sequenced. However, since the controls were not well matched by ethnic background to this patient, who is African-American, the possibility remains that the sequence difference is an inconsequential polymorphism. We also found a length polymorphism of 8 bp in intron 4 (data not shown). Further studies will be needed to determine if the Pro→Leu coding change has any effect on the function of DMRT1.
To test whether DMRT2 point mutations might be a frequent cause of XY sex reversal, we sequenced genomic DNA from 54 XY females. Because the DM domain is the site of most loss-of-function mutations in the mab-3 and dsx genes (30,34), we focused on the exon encoding the DM domain of DMRT2. We found a C→G polymorphism outside the DM domain in six patients (data not shown), but found no base changes in the DM domain. This suggests that, as with DMRT1, mutations in DMRT2 may not be a common cause of XY sex reversal, although we cannot exclude the possibility of mutations elsewhere in DMRT2.
Our failure to find multiple mutations in DMRT1 or DMRT2 in a relatively large group of XY females suggests at least three possibilities. The first is that neither gene plays a role in sex determination. The second is that we may have sequenced an insufficient number of alleles or that mutations may occur outside the sequenced regions of either gene (see below). An alternative possibility is that the two genes have at least partially overlapping functions and sex reversal in 9p-deleted individuals results from hemizygosity of both genes.
Sex-reversing 9p deletions remove both DMRT1 and DMRT2
Based on the extremely distal positions of DMRT1 and DMRT2 in 9p24.3, both genes would be expected to be hemizygous in all previously reported XY females with 9p deletions. To test this prediction, we performed FISH analysis on cells from two 46,XY patients with 9p deletions. The extents of the deletions in these patients are indicated in Figure 4B .
Patient 1, who is newly reported here, presented with ambiguous external genitalia, including a normal size phallus, penoscrotal transposition, non-palpatable testes and severe hypospadias. At the time of surgical repair, bilateral undescended testes were identified and characterized as very small and cystic in appearance. Gbanded chromosome analysis of skin fibroblasts revealed a 46,XY male complement with one normal chromosome 9 and one ring chromosome 9, as shown in Figure 4A . Breakpoints within the ring were designated at bands 9p23 and 9q34.3, resulting in monosomy for the regions 9p23-9pter (Fig. 4B ) and 9q34.3-9qter. FISH with probes to DMRT1 and DMRT2 confirmed a deletion of both genes within the ring chromosome (Fig. 5A) .
Patient 2, who has been described previously, presented at 3 years of age with female external genitalia and female internal structures, which included a uterus, vagina and dysgenic gonads, and has the smallest reported 9p deletion (25, 28, 36) . The patient's father has a balanced 8;9 translocation (25). The patient inherited a normal maternal chromosome 9 and a paternal chromosome 9 in which the distal short arm is replaced by an extra copy of the distal short arm of chromosome 8. Previous cytogenetic and molecular analysis of DNA from this patient showed that the deletion breakpoint is in 9p24.3, distal to the marker D9S1779, narrowing the critical region for sex reversal to the terminal portion of 9p24.3. FISH with probes to DMRT1 and DMRT2 on EBV-transformed lymphoblastoid cells derived from the father showed hybridization of both probes to one chromosome 9 and one chromosome 8 (presumably the 8;9 derivative) (Fig. 5B) . In cells derived from the patient, the probes hybridize to only one chromosome 9 (Fig.  5C) . Thus, the father has two copies of DMRT1 and DMRT2, while the 46,XY daughter is hemizygous for both genes. 
DISCUSSION
We have found that two DM domain-containing genes, DMRT1 and DMRT2, map within 9p24.3, a region that is critical for testis development. Sequencing of the coding region of DMRT1 from a large group of unexplained XY females identified only one potential point mutation. Similarly, sequencing of the DM domain of DMRT2 failed to identify any point mutations. This result suggests that mutation of either DMRT1 or DMRT2 alone is not sufficient to cause XY sex reversal. Despite the lack of point mutations in DMRT1 and DMRT2, FISH analysis of the smallest reported sex-reversing 9p deletion shows the absence of both genes, implying that all sexreversing 9p deletions reported thus far remove both genes. Therefore, we suggest that sex reversal in 9p-deleted individuals might be due to hemizygosity of both DMRT1 and DMRT2.
The model we suggest for 9p deletion sex reversal involves at least partial functional redundancy between DMRT1 and DMRT2. The two proteins are highly similar in the DM domain, but less similar in their N-and C-terminal domains. One might expect two functionally redundant proteins to be highly similar throughout. However, comparison of the DSX and MAB-3 proteins illustrates that this need not be the case. Despite substantial differences in protein sequence, MAB-3 and DSX bind to similar DNA sequences in vitro and in vivo and are functionally interchangeable in vivo (30, 37) . From these results it is clear that DM domain proteins need not be highly similar in primary sequence to perform related functions in vivo. Similarly, the SRY protein is evolutionarily conserved only in the HMG domain; the rest of the protein appears to have evolved rapidly (38) .
Several possible mechanisms have been proposed for XY sex reversal associated with 9p deletions, including haploinsufficiency of the deleted gene(s) or the uncovering of a recessive mutation on the remaining chromosome. The relatively high frequency of XY sex reversal observed in 9p deletion syndrome suggests haploinsufficiency, because otherwise the frequency of pre-existing mutant alleles would have to be correspondingly high. If DMRT1 and/or DMRT2 are involved in sex reversal associated with 9p deletions, our sequencing data and FISH analysis are also consistent with haploinsufficiency. It is clear that the process of sex determination is highly sensitive to gene dosage and activity. For example, the same mutant allele of SRY can be present in a fertile male father and an XY female offspring, demonstrating that there is a sensitive threshold for SRY activity that may vary between individuals. Similarly, of the other genes and loci known to be required for gonad formation and sex determination, there is evidence of sensitive activity thresholds of SOX9, WT1 and DSS, as well as the gene(s) on 9p (1, 6, 10, 16, (39) (40) (41) (42) .
9p deletions are associated with variable sexual phenotypes and some 46,XY individuals with 9p deletions are phenotypic males. There are several possible explanations for this variabil- ity. First, as discussed above, if hemizygosity of DMRT1 and DMRT2 or other genes is responsible, there may be a sensitive threshold for the activity of the gene(s), resulting in incomplete penetrance, with some individuals unaffected. We favor this possibility. Second, variability in the extent of sex reversal could be due to deletion of a variable number of sex-determining genes. While this is possible, it is unlikely, because there is no apparent correlation between the extent of 9p deletions and the severity of XY feminization. For example, of the two patients described in this study, the more completely feminized patient has the smaller 9p deletion. Third, variability due to imprinting is possible, but is unlikely, as there is no correlation between the parental origin of the affected chromosome 9 and the severity of sex reversal (17, 43) . In addition to these possibilities, some cases of 9p deletion that do not cause sex reversal may prove upon further analysis to be interstitial deletions that retain subtelomeric loci, including DMRT1 and DMRT2.
The DNA sequencing data presented here suggest that point mutations in the DMRT1 and DMRT2 coding regions are not a frequent cause of XY sex reversal. We cannot, however, exclude the frequent occurrence of small deletions or regulatory mutations in DMRT1 or DMRT2 in 46,XY females: if a deletion removed one or both PCR primer-binding sites, we would fail to amplify the affected allele and as a result would sequence only the unaffected exon. Likewise, we cannot exclude as a cause of sex reversal the occurrence of cytogenetically undetectable lesions that remove the entire DMRT1 or DMRT2 gene. It is important to note that the patients examined here are fully or nearly fully feminized. Thus, it remains possible that point mutations in DMRT1 or DMRT2 might cause a less severe intersexual phenotype. It is also possible that homozygous mutations in either gene have a more pleiotropic phenotype.
There are now three lines of circumstantial evidence that make DMRT1 and DMRT2 likely candidates to be involved in mammalian sexual development. First, both are related to proven sex-determining genes that are conserved between insects and nematodes. Second, both genes are located in a very short (~250 kb) chromosomal region that is essential for testis development. Currently these are the only candidate genes identified in the critical region. Third, both genes are expressed in the adult testis. To definitively establish the roles of DMRT1 and DMRT2 in sex determination it will be necessary to disrupt these two genes in the mouse, individually and together; these experiments are underway.
MATERIALS AND METHODS
Library screening
A human placental genomic DNA λ library (Clontech, Palo Alto, CA) was screened with a 32 P-labeled DMRT1 cDNA clone (GenBank accession no. AA412330). Single positive plaques were isolated and DNA was prepared from liquid lysates. Human DMRT2-containing genomic clones were isolated by screening the human genomic DNA library at low stringency using a mouse Dmrt2 cDNA fragment (C.S. Raymond, J.R. Kettlewell, E.D. Parker, K.J. Seifert, B. Hirsch, V.J. Bardwell and D. Zarkower, manuscript submitted for publication) as a probe. A human DMRT2 cDNA clone was isolated by probing a testis λ phage cDNA library (Clontech) with a genomic DNA fragment encoding the DMRT2 DM domain. Database searches using this cDNA sequence identified an expressed sequence tag (EST) sequence (GenBank accession no. Z24950) from a human female skeletal muscle cDNA library. (A) FISH analysis of patient 1 for DMRT1 (small red signal) and DMRT2 (small green signal). DMRT1 and DMRT2 hybridization (arrow) is detected on the normal chromosome 9 but not on the ring chromosome 9. Large red signals represent hybridization of a chromosome 9 centromeric probe. (B) FISH analysis of the father of patient 2 for DMRT1 (small red signal) and DMRT2 (small green signal). DMRT1 and DMRT2 hybridization (arrows) is detected on one chromosome 9 (large red signal from chromosome 9 centromeric probe) and one chromosome 8 (as previously determined by G-banding). The other chromosome 9 is hybridized only by the centromeric probe (large red signal). (C) FISH analysis of patient 2 for DMRT1 (red) and DMRT2 (green). DMRT1 and DMRT2 hybridization (arrow) is detected only on one chromosome 9. The close proximity of DMRT1 and DMRT2 on chromosome 9 often results in an overlapping (yellow) signal on metaphase chromosomes.
FISH analysis
FISH (44) was performed using DMRT1 and DMRT2 genomic λ phage clones labeled by nick translation with digoxigenin-11-dUTP or biotin-16-dUTP (Boehringer Mannheim, Indianapolis, IN) and detected with rhodamine-anti-digoxigenin or fluorescein-conjugated avidin, respectively. Signals were further amplified using rabbit anti-sheep and rhodamine-antirabbit (for the digoxigenin-labeled probe) or anti-avidin and fluorescein-conjugated avidin (for the biotin-labeled probe). A directly labeled Spectrum Orange or Spectrum Green (VYSIS, Downers Grove, IL) chromosome 9 centromere probe (D9Z1) was also applied. Chromosomes were counterstained with 4,6'-diamidino-2-phenylindole. In each case at least 10 metaphase cells were examined using fluorescent microscopy and images were captured using CytoVision software (Applied Imaging, Santa Clara, CA).
DNA amplification and sequencing
Genomic DNA from lymphoblastoid cells of 87 XY females, 17 XX males and 92 normal controls was used as a template to amplify each DMRT1 exon and immediate flanking sequence by PCR. PCR reactions were incubated at 94°C for 1 min, followed by 40 cycles of 94°C for 30 s, 55°C for 30 s and 72°C for 1 min. Reactions included 10% DMSO. PCR products were purified using the High Pure PCR Product Purification kit (Boehringer Mannheim) and analyzed on 1% agarose gels. The PCR products were directly sequenced using the Thermo Sequenase radiolabeled dideoxy nucleotide terminator cycle sequencing kit (USB, Cleveland, OH). Sequence reactions were run on 6% denaturing polyacrylamide gels and were autoradiographed overnight.
For each exon of DMRT1 a genomic DNA fragment encompassing the exon was amplified and directly sequenced as follows. Exon 1 was amplified with primers E1FA and E1RA and sequenced on one strand with two internal primers (E1FS and CR76). Exons 2 and 3 were amplified and both strands were sequenced using the same primers (E2FS, E2RS, E3FS and E3RS). Exons 4 and 5 were amplified with E4F and E4R and with E5F and CR64, respectively, and sequenced with E4F or E5F. Primer sequences are from introns and 5'-and 3'-UTRs, allowing sequencing of the full coding region and all splice junctions. In all cases where both strands were sequenced, polymorphisms detected on one strand were also detected on the other. DMRT2 was amplified with primers JK7 and JK8 and sequenced with JK10. Primer sequences were as follows. Primers for DMRT1: E1FA, CTCCGGAGCGTCGCTGTCCGTCGG; E1RA, GAGCCAAGATCGCGCCACTACACTGC; E1FS, TCCCTGGCAGCAGTCTCCAGGCGAG; E1RS, AGCCTGGC-AACCGAGCGAGACTC; E2FS, GTGTTTTGGCAAAGCT-GATTCTGG; E2RS, TGCAACCTTCGGCCTCCCTCATGC; E3FS, AGAAGTAAAGTTTCGTGGACTAAC; E3RS, TGCA-CATGCATGTGGCTTTCACAC; E4F, CACTGTGCCCAGCC-TGTTACCTTG; E4R, AAGCCATTAGACACAGCTAATGAC; E5F, GAATAATGAATGTATAAAGACCAGCCAC; CR64, CAGCCTCTGGACTAAACTCTAAGG; CR76, GGCAAAG-CGTCTGGGGCGCTAGTG. Primers for DMRT2: JK7, GTGGACGAAGACGCGGAAGAAGAG; JK8, GCACCTCG-GTGGCCTGCTGCCTCC; JK10, CGACGGCGAGGAGGCAG-GCGCGTC.
